Epistaxis Market 2025 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Epistaxis Device Market to 2025 - Global Analysis and Forecasts By Product (Nasal Tampons, Nasal Packing, Others), By End User (Patients, Hospitals & Clinics, Others ), and Geography

Report Code: TIPHE100001304 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Epistaxis is medical condition which causes bleeding from the nostril, nasal cavity, or nasopharynx. The bleeding of nose is due to bursting of blood vessel within the nose. Epistaxis may be spontaneous or caused by trauma, internal injury or nose pricking.

The epistaxis Device market is anticipated to grow with a significant rate in the coming years owing to factors such as, increasing prevalence and incidence of nasal membrane rupture and abnormal nose bleeding Furthermore, manufacturers are also focusing in developing epistaxis products for the treatment of patients, .

The "Global Epistaxis Device Market Analysis to 2025" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global epistaxis Device market with detailed market segmentation by product, end user and geography. The global epistaxis Device market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

The global epistaxis Device market is segmented on the basis of product, end user, and geography. The product segment includes, nasal tampons, nasal packing, others. Based on end user, the market is segmented as, patients, hospitals & clinics, others.

The epistaxis Device market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Epistaxis Device market based on product, end user, and geography. It also provides market size and forecast till 2025 for overall Epistaxis Device market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the epistaxis Device market in the coming years, owing to factors such as, improved healthcare infrastructure and rising number of hypertension patients in United States and Canada. Asia Pacific is expected to witness significant growth rate during the forecast period primarily due to the growth of healthcare industry in Asian countries such as, India, China and Japan.

The epistaxis Device market report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key epistaxis Device market manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Medline, King Pharmaceuticals, Inc., Smith & Nephew, Summit Medical, Inc., Cirondrugs, Medtronic, GlaxoSmithKline plc, CogENT Therapeutics, Entellus Medical, Inc., and Bristol-Myers Squibb
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. KEY TAKEAWAYS

3. EPISTAXIS MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Epistaxis Market - By Product
3.2.2. Epistaxis Market - By End User
3.2.3. Epistaxis Market - By Geography
3.2.3.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis

4. EPISTAXIS MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS

5. EPISTAXIS MARKET - GLOBAL ANALYSIS
5.1. GLOBAL EPISTAXIS MARKET OVERVIEW
5.2. GLOBAL EPISTAXIS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. MARKET POSITIONING/MARKET SHARE
5.4. PERFORMANCE OF KEY PLAYERS
5.5. EXPERT OPINIONS

6. EPISTAXIS MARKET- GLOBAL REGULATORY SCENARIO
6.1. OVERVIEW
6.2. NORTH AMERICA
6.3. EUROPE
6.4. ASIA PACIFIC
6.5. MIDDLE EAST & AFRICA
6.6. SOUTH AND CENTRAL AMERICA

7. EPISTAXIS MARKET REVENUE AND FORECASTS TO 2025 - BY PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. PRODUCT MARKET VOLUME AND FORECASTS ANALYSIS ('000 UNITS)
7.4. NASAL PACKING MARKET
7.4.1. Overview
7.4.2. Nasal packing Market Revenue Forecasts and Analysis (US$ Mn)
7.4.3. Nasal packing Market Volume Forecasts and Analysis ('000 Units)
7.5. NASAL TAMPONS MARKET
7.5.1. Overview
7.5.2. Nasal Tampons Market Revenue Forecasts and Analysis (US$ Mn)
7.5.3. Nasal Tampons Market Volume Forecasts and Analysis ('000 Units)
7.6. OTHERS MARKET
7.6.1. Overview
7.6.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
7.6.3. Others Market Volume Forecasts and Analysis ('000 Units)

8. EPISTAXIS MARKET REVENUE AND FORECASTS TO 2025 - BY END USER
8.1. OVERVIEW
8.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. PATIENTS MARKET
8.3.1. Overview
8.3.2. Patients Market Revenue Forecasts and Analysis (US$ Mn)
8.4. HOSPITALS & CLINICS MARKET
8.4.1. Overview
8.4.2. Hospitals & clinics Market Revenue Forecasts and Analysis (US$ Mn)
8.5. OTHERS MARKET
8.5.1. Overview
8.5.2. Others Market Revenue Forecasts and Analysis (US$ Mn)

9. NORTH AMERICA EPISTAXIS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
9.1. NORTH AMERICA EPISTAXIS MARKET OVERVIEW
9.2. NORTH AMERICA EPISTAXIS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. NORTH AMERICA EPISTAXIS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
9.4. NORTH AMERICA EPISTAXIS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
9.5. NORTH AMERICA EPISTAXIS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
9.6. US MARKET OVERVIEW
9.6.1. US Epistaxis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.6.2. US Epistaxis Market Revenue Forecasts and Analysis - By end user $ Mn)
9.7. CANADA MARKET OVERVIEW
9.7.1. Canada Epistaxis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.7.2. Canada Epistaxis Market Revenue Forecasts and Analysis - By end user (US$ Mn)
9.8. MEXICO MARKET OVERVIEW
9.8.1. Mexico Epistaxis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.8.2. Mexico Epistaxis Market Revenue Forecasts and Analysis - By end user (US$ Mn)

10. EUROPE EPISTAXIS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
10.1. EUROPE EPISTAXIS MARKET OVERVIEW
10.2. EUROPE EPISTAXIS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. EUROPE EPISTAXIS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
10.4. EUROPE EPISTAXIS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.5. EUROPE EPISTAXIS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
10.6. UK MARKET OVERVIEW
10.6.1. UK Epistaxis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.6.2. UK Epistaxis Market Revenue Forecasts and Analysis - By end user (US$ Mn)
10.7. GERMANY MARKET OVERVIEW
10.7.1. Germany Epistaxis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.7.2. Germany Epistaxis Market Revenue Forecasts and Analysis - By end user (US$ Mn)
10.8. FRANCE MARKET OVERVIEW
10.8.1. France Epistaxis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.8.2. France Epistaxis Market Revenue Forecasts and Analysis - By end user (US$ Mn)

11. ASIA PACIFIC EPISTAXIS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
11.1. ASIA PACIFIC EPISTAXIS MARKET OVERVIEW
11.2. ASIA PACIFIC EPISTAXIS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. ASIA PACIFIC EPISTAXIS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
11.4. ASIA PACIFIC EPISTAXIS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.5. ASIA PACIFIC EPISTAXIS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
11.6. JAPAN MARKET OVERVIEW
11.6.1. Japan Epistaxis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.6.2. Japan Epistaxis Market Revenue Forecasts and Analysis - By end user (US$ Mn)
11.7. CHINA MARKET OVERVIEW
11.7.1. China Epistaxis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.7.2. China Epistaxis Market Revenue Forecasts and Analysis - By end user (US$ Mn)
11.8. INDIA MARKET OVERVIEW
11.8.1. India Epistaxis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.8.2. India Epistaxis Market Revenue Forecasts and Analysis - By end user (US$ Mn)

12. MIDDLE EAST AND AFRICA (MEA) EPISTAXIS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
12.1. MIDDLE EAST AND AFRICA EPISTAXIS MARKET OVERVIEW
12.2. MIDDLE EAST AND AFRICA EPISTAXIS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. MIDDLE EAST AND AFRICA EPISTAXIS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
12.4. MIDDLE EAST AND AFRICA EPISTAXIS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.5. MIDDLE EAST AND AFRICA EPISTAXIS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
12.6. SOUTH AFRICA MARKET OVERVIEW
12.6.1. South Africa Epistaxis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.6.2. South Africa Epistaxis Market Revenue Forecasts and Analysis - By end user (US$ Mn)
12.7. SAUDI ARABIA MARKET OVERVIEW
12.7.1. Saudi Arabia Epistaxis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.7.2. Saudi Arabia Epistaxis Market Revenue Forecasts and Analysis - By end user (US$ Mn)
12.8. UAE MARKET OVERVIEW
12.8.1. UAE Epistaxis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.8.2. UAE Epistaxis Market Revenue Forecasts and Analysis - By end user (US$ Mn)

13. SOUTH AND CENTRAL AMERICA EPISTAXIS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
13.1. SOUTH AND CENTRAL AMERICA EPISTAXIS MARKET OVERVIEW
13.2. SOUTH AND CENTRAL AMERICA EPISTAXIS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. SOUTH AND CENTRAL AMERICA EPISTAXIS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
13.4. SOUTH AND CENTRAL AMERICA EPISTAXIS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
13.5. SOUTH AND CENTRAL AMERICA EPISTAXIS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
13.6. BRAZIL MARKET OVERVIEW
13.6.1. Brazil Epistaxis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
13.6.2. Brazil Epistaxis Market Revenue Forecasts and Analysis - By end user (US$ Mn)

14. INDUSTRY LANDSCAPE
14.1. ORGANIC GROWTH STRATEGIES
14.1.1. New Product Launches
14.1.2. Marketing & Promotional Activities
14.2. INORGANIC GROWTH STRATEGIES
14.2.1. Partnerships, Collaborations, and Joint Ventures
14.2.2. Mergers & Acquisitions

15. EPISTAXIS MARKET, KEY COMPANY PROFILES
15.1. MEDLINE
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Financial Overview
15.1.4. Product Portfolio
15.1.5. Product Pipeline
15.1.6. SWOT Analysis
15.1.7. Key Developments
15.2. KING PHARMACEUTICALS, INC.
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Financial Overview
15.2.4. Product Portfolio
15.2.5. Product Pipeline
15.2.6. SWOT Analysis
15.2.7. Key Developments
15.3. SMITH & NEPHEW
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Financial Overview
15.3.4. Product Portfolio
15.3.5. Product Pipeline
15.3.6. SWOT Analysis
15.3.7. Key Developments
15.4. SUMMIT MEDICAL, INC.
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Financial Overview
15.4.4. Product Portfolio
15.4.5. Product Pipeline
15.4.6. SWOT Analysis
15.4.7. Key Developments
15.5. CIRONDRUGS
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Financial Overview
15.5.4. Product Portfolio
15.5.5. Product Pipeline
15.5.6. SWOT Analysis
15.5.7. Key Developments
15.6. MEDTRONIC
15.6.1. Business Description
15.6.2. Financial Overview
15.6.3. Product Portfolio
15.6.4. Product Pipeline
15.6.5. SWOT Analysis
15.6.6. Key Developments
15.7. GlaxoSmithKline plc
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Financial Overview
15.7.4. Product Portfolio
15.7.5. Product Pipeline
15.7.6. SWOT Analysis
15.7.7. Key Developments
15.8. CogENT Therapeutics
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Financial Overview
15.8.4. Product Portfolio
15.8.5. Product Pipeline
15.8.6. SWOT Analysis
15.8.7. Key Developments
15.9. ENTELLUS MEDICAL, INC.
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Financial Overview
15.9.4. Product Portfolio
15.9.5. Product Pipeline
15.9.6. SWOT Analysis
15.9.7. Key Developments
15.10. BRISTOL-MYERS SQUIBB
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Financial Overview
15.10.4. Product Portfolio
15.10.5. Product Pipeline
15.10.6. SWOT Analysis
15.10.7. Key Developments

16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
16.3. RESEARCH METHODOLOGY
The List of Companies

1. Medline
2. King pharmaceuticals, inc.
3. Smith & nephew
4. Summit medical, inc.
5. Cirondrugs
6. Medtronic
7. Glaxosmithkline plc
8. Cogent therapeutics
9. Entellus medical, inc.
10. Bristol-myers squibb

Select License Type
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book